Transcept Pharmaceuticals (TSPT)
Transcept Pharmaceuticals Balance Sheet
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Assets | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Cash & Short Term Investments | 59.40M | 62.56M | 54.27M | 59.83M | 63.49M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Receivables | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Inventory | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Prepaid Expenses | 1.937M | 3.275M | 1.038M | 1.169M | 1.462M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Current Assets | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Assets | 61.34M | 65.84M | 55.31M | 61.00M | 64.95M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Property, Plant & Equipment | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Accumulated Depreciation | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Property, Plant & Equipment | 0.25M | 0.314M | 0.365M | 0.438M | 0.511M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Long Term Investments | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Goodwill & Intangibles | 2.962M | 2.962M | 2.962M | 2.962M | 2.962M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Long Term Assets | 0.038M | 0.038M | 0.808M | 0.808M | 0.808M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Assets | 3.25M | 3.314M | 4.135M | 4.208M | 4.281M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Assets | 64.59M | 69.15M | 59.44M | 65.20M | 69.23M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Liabilities | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Current Portion of Long Term Debt | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Accounts Payable | 0.968M | 0.987M | 0.647M | 1.191M | 0.759M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Accrued Expenses | 1.447M | 2.108M | 0.972M | 1.197M | 1.058M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Revenues | 0.417M | 1.042M | 4.167M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||
| Other Current Liabilities | 0.182M | 0.244M | 0.306M | 0.298M | 0.324M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Current Liabilities | 2.597M | 3.339M | 2.342M | 3.728M | 6.308M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Debt | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Shareholder's Equity | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Deferred Income Tax | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Long Term Liabilities | 0.039M | 0.06M | 0.094M | 0.177M | 0.261M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Liabilities | 0.039M | 0.06M | 0.094M | 0.177M | 0.261M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities | 2.636M | 3.399M | 2.436M | 3.905M | 6.569M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Common Shares Outstanding | 18.54M | 13.54M | 13.52M | 13.48M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Preferred Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Common Stock, Net | 0.014M | 0.014M | 0.014M | 0.014M | 0.013M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Additional Paid-in Capital | 167.21M | 165.80M | 162.35M | 161.64M | 160.78M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Retained Earnings | -105.27M | -100.09M | -105.39M | -100.40M | -98.15M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Treasury Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Shareholder's Equity | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Shareholder's Equity | 61.96M | 65.75M | 57.01M | 61.30M | 62.66M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities & Shareholder's Equity | 64.59M | 69.15M | 59.44M | 65.20M | 69.23M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |